These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
55 related articles for article (PubMed ID: 10837517)
1. [Detection of point mutations in promoter and coding sequence of p21 gene in a variety of human malignancies]. Huang Q; Tao Y Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Jun; 17(3):169-72. PubMed ID: 10837517 [TBL] [Abstract][Full Text] [Related]
2. Polymorphisms and probable lack of mutation in the WAF1-CIP1 gene in colorectal cancer. Li YJ; Laurent-Puig P; Salmon RJ; Thomas G; Hamelin R Oncogene; 1995 Feb; 10(3):599-601. PubMed ID: 7845685 [TBL] [Abstract][Full Text] [Related]
3. Mutational analysis of the p21/WAF1/CIP1/SDI1 coding region in human tumor cell lines. Terry LA; Boyd J; Alcorta D; Lyon T; Solomon G; Hannon G; Berchuck A; Beach D; Barrett JC Mol Carcinog; 1996 Aug; 16(4):221-8. PubMed ID: 8784465 [TBL] [Abstract][Full Text] [Related]
4. A single nucleotide substitution at codon 31 (Ser/Arg) defines a polymorphism in a highly conserved region of the p53-inducible gene WAF1/CIP1. Chedid M; Michieli P; Lengel C; Huppi K; Givol D Oncogene; 1994 Oct; 9(10):3021-4. PubMed ID: 8084608 [TBL] [Abstract][Full Text] [Related]
5. A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma. Bhatia K; Fan S; Spangler G; Weintraub M; O'Connor PM; Judde JG; Magrath I Cancer Res; 1995 Apr; 55(7):1431-5. PubMed ID: 7882347 [TBL] [Abstract][Full Text] [Related]
6. Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer. Ralhan R; Agarwal S; Mathur M; Wasylyk B; Srivastava A Clin Cancer Res; 2000 Jun; 6(6):2440-7. PubMed ID: 10873097 [TBL] [Abstract][Full Text] [Related]
7. p53 and p21 genetic polymorphisms and susceptibility to endometrial cancer. Roh JW; Kim JW; Park NH; Song YS; Park IA; Park SY; Kang SB; Lee HP Gynecol Oncol; 2004 May; 93(2):499-505. PubMed ID: 15099969 [TBL] [Abstract][Full Text] [Related]
8. C-terminal deletion mutant p21(WAF1/CIP1) enhances E2F-1-mediated apoptosis in colon adenocarcinoma cells. Elliott MJ; Stilwell A; Dong YB; Yang HL; Wong SL; Wrightson WR; Martin RC; McMasters KM Cancer Gene Ther; 2002 May; 9(5):453-63. PubMed ID: 11961668 [TBL] [Abstract][Full Text] [Related]
9. ING1 represses transcription by direct DNA binding and through effects on p53. Kataoka H; Bonnefin P; Vieyra D; Feng X; Hara Y; Miura Y; Joh T; Nakabayashi H; Vaziri H; Harris CC; Riabowol K Cancer Res; 2003 Sep; 63(18):5785-92. PubMed ID: 14522900 [TBL] [Abstract][Full Text] [Related]
10. [Mutations of several tumor suppressor genes in primary retinoblastoma]. Huang Q; Tao Y; Yandell DW Zhonghua Zhong Liu Za Zhi; 1999 Jan; 21(1):10-2. PubMed ID: 11776785 [TBL] [Abstract][Full Text] [Related]
11. p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elements. Campomenosi P; Monti P; Aprile A; Abbondandolo A; Frebourg T; Gold B; Crook T; Inga A; Resnick MA; Iggo R; Fronza G Oncogene; 2001 Jun; 20(27):3573-9. PubMed ID: 11429705 [TBL] [Abstract][Full Text] [Related]
12. Absence of somatic changes in p21 gene in non-Hodgkin's lymphoma and chronic myelogenous leukemia. Gong JZ; Zhou H; Hu Z; Schulman P; Vinceguerra V; Broome JD; Koduru P Hematol Pathol; 1995; 9(3-4):171-7. PubMed ID: 8655461 [TBL] [Abstract][Full Text] [Related]
13. Association between human cancer and two polymorphisms occurring together in the p21Waf1/Cip1 cyclin-dependent kinase inhibitor gene. Facher EA; Becich MJ; Deka A; Law JC Cancer; 1997 Jun; 79(12):2424-9. PubMed ID: 9191533 [TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the expression of cell cycle regulating proteins: cyclin D1, P53 and P21 (WAF1) in colorectal cancer. Pasz-Walczak G; Kordek R Pol J Pathol; 2000; 51(2):63-9. PubMed ID: 10974928 [TBL] [Abstract][Full Text] [Related]
15. Activation of the p21WAF1/CIP1 promoter independent of p53 by the histone deacetylase inhibitor suberoylanilide hydroxamic acid (SAHA) through the Sp1 sites. Huang L; Sowa Y; Sakai T; Pardee AB Oncogene; 2000 Nov; 19(50):5712-9. PubMed ID: 11126357 [TBL] [Abstract][Full Text] [Related]
17. Adenoviral-mediated gene therapy with Ad5CMVp53 and Ad5CMVp21 in combination with standard therapies in human breast cancer cell lines. Parker LP; Wolf JK; Price JE Ann Clin Lab Sci; 2000 Oct; 30(4):395-405. PubMed ID: 11045764 [TBL] [Abstract][Full Text] [Related]
18. Transactivation of the p21 promoter by BRCA1 splice variants in mammary epithelial cells: evidence for both common and distinct activities of wildtype and mutant forms. Lu M; Arrick BA Oncogene; 2000 Dec; 19(54):6351-60. PubMed ID: 11175350 [TBL] [Abstract][Full Text] [Related]
19. Perifosine, a novel alkylphospholipid, induces p21(WAF1) expression in squamous carcinoma cells through a p53-independent pathway, leading to loss in cyclin-dependent kinase activity and cell cycle arrest. Patel V; Lahusen T; Sy T; Sausville EA; Gutkind JS; Senderowicz AM Cancer Res; 2002 Mar; 62(5):1401-9. PubMed ID: 11888912 [TBL] [Abstract][Full Text] [Related]
20. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Seoane J; Le HV; Massagué J Nature; 2002 Oct; 419(6908):729-34. PubMed ID: 12384701 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]